Journal Article Summary
The article investigates the prevalence of aspirin resistance in patients with congenital heart disease (CHD) who have undergone transcatheter pulmonary valve replacement (TPVR). This topic is significant because aspirin is commonly prescribed to prevent thromboembolic events, which can occur after valve replacement procedures. Understanding how many patients may not respond effectively to aspirin is crucial for improving patient outcomes and ensuring appropriate treatment strategies.
The study involved a retrospective review of medical records from 48 CHD patients who had successful TPVR and underwent aspirin reactivity testing between May 2022 and December 2023. The researchers used a specific test to measure platelet aggregation, identifying aspirin resistance in 6.7% of the patients, all of whom were female. Interestingly, while some patients experienced thromboembolic events, these occurred exclusively in those who were sensitive to aspirin, suggesting that aspirin resistance did not correlate with an increased risk of such events.
However, the study has limitations, including a small sample size and the absence of a control group, which makes it challenging to draw broader conclusions. Additionally, the reliance on retrospective data may have led to missed information regarding adverse events. Patients are encouraged to discuss their aspirin therapy and any concerns about thromboembolic risks with their healthcare providers, especially considering the findings related to gender differences in aspirin resistance.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Sigman Alex, Riley Emily, Pierick Trudy, Aldoss Osamah, Porayette Prashob. Prevalence of Aspirin Resistance in Patients with Transcatheter Pulmonary Valve Replacement. Catheterization and Cardiovascular Interventions 2025. DOI: 10.1002/ccd.31440. PMID: 39930947. PMCID: PMC11962822.
Featured Pill Pals Product
OTC 1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
